A recent large-scale study led by the University of Bristol has found a potential link between lower cholesterol levels and a reduced risk of developing dementia. The research, which analyzed data from over one million participants, focused on individuals with genetic traits that naturally lower cholesterol levels. The study was led by Dr. Liv Tybjærg Nordestgaard and published in the journal Alzheimer's & Dementia.
Utilizing a method known as Mendelian Randomization, the researchers examined how specific genetic variants that affect cholesterol levels relate to dementia risk. This approach allows for the assessment of genetic influences while minimizing confounding factors such as diet and lifestyle. The findings revealed that individuals with certain genetic traits that lower cholesterol levels experienced up to an 80% reduction in dementia risk linked to those genetic variants.
Dr. Nordestgaard noted that the results suggest maintaining lower cholesterol levels, whether through genetics or medical intervention, could offer some protection against dementia. However, the study does not establish that cholesterol-lowering medications directly prevent the disease.
The complexities of studying dementia, which often manifests later in life, pose challenges for establishing causation. One theory posits that high cholesterol may contribute to atherosclerosis, potentially leading to blood clots that increase dementia risk.
Dr. Nordestgaard emphasized the need for long-term randomized clinical trials to further investigate the relationship between cholesterol-lowering treatments and dementia risk. The research was supported by multiple organizations, including the Medical Research Council and Independent Research Fund Denmark, and utilized data from various population studies, highlighting the collaborative effort in exploring this important health issue.